Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,445 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
Lee KH, Lee JH, Lee JH, Kim DY, Kim SH, Shin HJ, Lee YS, Kang YA, Seol M, Ryu SG. Lee KH, et al. Among authors: lee ys, lee jh. Biol Blood Marrow Transplant. 2009 Jan;15(1):61-72. doi: 10.1016/j.bbmt.2008.10.025. Biol Blood Marrow Transplant. 2009. PMID: 19135944 Free article. Clinical Trial.
Randomized comparison of four-times-daily versus once-daily intravenous busulfan in conditioning therapy for hematopoietic cell transplantation.
Ryu SG, Lee JH, Choi SJ, Lee JH, Lee YS, Seol M, Hur EH, Lee SH, Bae KS, Noh GJ, Lee MS, Yun SC, Han SB, Lee KH. Ryu SG, et al. Among authors: lee sh, lee ms, lee ys, lee kh, lee jh. Biol Blood Marrow Transplant. 2007 Sep;13(9):1095-105. doi: 10.1016/j.bbmt.2007.06.005. Biol Blood Marrow Transplant. 2007. PMID: 17697972 Free article. Clinical Trial.
C3435T polymorphism of the MDR1 gene is not associated with P-glycoprotein function of leukemic blasts and clinical outcome in patients with acute myeloid leukemia.
Hur EH, Lee JH, Lee MJ, Choi SJ, Lee JH, Kang MJ, Seol M, Jang YE, Lee HJ, Kang IS, Shim SK, Ryu SG, Kang YA, Lee YS, Park CJ, Chi HS, Lee KH. Hur EH, et al. Among authors: lee ys, lee mj, lee kh, lee jh, lee hj. Leuk Res. 2008 Oct;32(10):1601-4. doi: 10.1016/j.leukres.2007.12.013. Epub 2008 Feb 12. Leuk Res. 2008. PMID: 18272218
Clinical significance of GSTM1 and GSTT1 polymorphisms in younger patients with acute myeloid leukemia of intermediate-risk cytogenetics.
Lee HS, Lee JH, Hur EH, Lee MJ, Lee JH, Kim DY, Kim SH, Seol M, Kang SI, Ryu SG, Kang YA, Lee YS, Kang MJ, Seo EJ, Kim YS, Chi HS, Park CJ, Jang S, Yun SC, Lee KH. Lee HS, et al. Among authors: lee ys, lee mj, lee kh, lee jh. Leuk Res. 2009 Mar;33(3):426-33. doi: 10.1016/j.leukres.2008.07.021. Epub 2008 Aug 29. Leuk Res. 2009. PMID: 18760837
Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia.
Lee SS, Lee JH, Lee JH, Kim DY, Kim SH, Lim SN, Lee YS, Seol M, Ryu SG, Kang YA, Jang S, Park CJ, Chi HS, Yun SC, Lee KH. Lee SS, et al. Among authors: lee ys, lee kh, lee jh. Leuk Res. 2009 Apr;33(4):511-7. doi: 10.1016/j.leukres.2008.08.009. Epub 2008 Sep 25. Leuk Res. 2009. PMID: 18819710 Clinical Trial.
8,445 results